BGS649 Monotherapy in Moderate to Severe Endometriosis Patients

NCT01190475 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis

Interventions

DRUG: Active treatment with a high dose of BGS649
DRUG: Active treatment with a low dose of BGS649
DRUG: Placebo treatment to blind study

Sponsor

Mereo BioPharma

Collaborators

[object Object]